CJC-1295 (No DAC)

🔬 Product Overview

CJC-1295 (No DAC) is a synthetic tetradecapeptide and growth hormone–releasing hormone (GHRH) analogue.

It is designed for short-term receptor interaction without the drug affinity complex (DAC) modification, allowing researchers to study natural pulsatile growth hormone release.

CJC-1295 (No DAC) is widely used in laboratory research involving endocrine signalling, peptide receptor activation, and GH axis regulation.

🧬 Peptide Sequence

·       Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Val–Leu–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg–Gln–Gln–Gly–Gly–Ser–Asn–Gln–Gln–Gly–Ala–Lys–Lys–Gln–Gly–Glu–Ser–Asn–Gln–Glu–Glu–Ala–Gln–Glu–Ala–Arg–Ala–Arg–Leu–Leu–Gly–Gly–Gly–Gly–Gly–NH₂

·       Molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂

·       Molecular weight: approximately 3357.88 g/mol

🧪 Structural Class

·       Tetradecapeptide (GHRH analogue)

·       Lacks DAC modification for natural half-life and transient receptor binding

·       Mimics endogenous GHRH interaction in controlled research environments

✅ Key Features

·       High-purity, research-grade peptide

·       Supplied as a lyophilised (freeze-dried) powder

·       Commonly used in in vitro research on growth hormone secretion and receptor modulation

·       Short-acting profile ideal for studying pulsatile GH release patterns

❄️ Storage Guidelines

·       Store the lyophilised peptide at –20°C

·       Once reconstituted with sterile solvent, keep refrigerated at 2–8°C

·       Avoid repeated freeze–thaw cycles to preserve peptide stability

⚠️ Intended Use

For laboratory research use only.
Not intended for human or veterinary use.
Not for diagnostic, therapeutic, or clinical applications.